Studies both in vivo and in vitro have shown that the biological response to 1,25(OH) 2 D 3 is directly related to the VDR content of target tissues (2, 3). Thus, understanding the regulation of the VDR is critical to our understanding of the vitamin D endocrine system. The receptor is developmentally regulated, expressed in a tissue-specific manner, and regulated by a variety of physiological factors and hormones, including calcium and 1,25(OH) 2 D 3 (4).
T
he vitamin D receptor (VDR) is a nuclear protein responsible for mediating the biological actions of vitamin D. 1,25-Dihydroxyvitamin D 3 [1, 25(OH) 2 D 3 ], the functional metabolite of vitamin D, exerts its actions by binding to the VDR and altering the transcriptional rate of target genes. The protein products of these genes then carry out the functions of vitamin D, including the maintenance of serum calcium and phosphorus homeostasis, regulation of cellular proliferation and differentiation, and modulation of the immune system (1) .
Studies both in vivo and in vitro have shown that the biological response to 1,25(OH) 2 D 3 is directly related to the VDR content of target tissues (2, 3) . Thus, understanding the regulation of the VDR is critical to our understanding of the vitamin D endocrine system. The receptor is developmentally regulated, expressed in a tissue-specific manner, and regulated by a variety of physiological factors and hormones, including calcium and 1,25(OH) 2 D 3 (4) .
The mechanism by which calcium and 1,25(OH) 2 D 3 regulate the VDR is not known. In vitro experiments in pig kidney cells (LLC-PK1), mouse fibroblasts (3T6), rat osteosarcoma cells (Ros 17͞2.8), and several human osteosarcoma cell lines (MG-63, SaOs-2, and U2-Os) have demonstrated that 1,25(OH) 2 D 3 up-regulates the VDR at least partially through the activation of gene expression (5) (6) (7) (8) . Experiments studying the autoregulation of the VDR in LLC-PK1, 3T6, Ros 17͞2.8, and rat intestinal epithelial (IEC-6) cells concluded that 1,25(OH) 2 D 3 increases VDR content primarily through stabilization of the receptor, because little or no increase in VDR mRNA was observed (9) (10) (11) . The ability of 1,25(OH) 2 D 3 to increase VDR content in vivo was first demonstrated by Costa and Feldman (12) , who noted that s.c.-injected 1,25(OH) 2 D 3 significantly up-regulated renal VDR, while having minimal effect on duodenal VDR. Subsequent experiments have demonstrated that whereas 1,25(OH) 2 D 3 and calcium do not impact expression of the VDR in the intestine, they do regulate VDR expression in the parathyroid gland and kidney (10, (13) (14) (15) . In rat kidney, vitamin D 3 or 1,25(OH) 2 D 3 supplementation has been shown to increase VDR content up to 5-fold, as long as dietary calcium is present (14, 16, 17 (21) . The protein concentration of the homogenates was determined by the method of Bradford (22) , using BSA as a standard.
RNA Isolation. Total RNA was isolated from mouse kidney with Tri reagent (Molecular Research Center, Cincinnati) according to the manufacturer's protocol.
Quantitative RT-PCR. RNA was DNase-treated (RQ-1 RNaseFree Dnase, Promega) and then reverse transcribed by using the SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen). Real-time PCR was performed in a LightCycler (Roche Diagnostics, Mannheim, Germany) according to the manufacturer's recommendations. SYBR green dye was used for quantification of dsDNA after every cycle. The sequence of primers designed for the quantification of ␤-actin, VDR, 25-hydroxyvitamin D 3 -1␣-hydroxylase (1␣-hydroxylase), and 25-hydroxyvitamin D 3 -24-hydroxylase (24-hydroxylase) follows: ␤-actin (F͞R; 5Ј-3Ј) TGGAATCCTGTGGCATCCAT-GAAAC͞TAAAACGCAGCTCAGTAACAGTCCG; VDR CTCCTCGATGCCCACCACA AGACCTACG͞GTGGG-GCAGCATGGAGAGCGGAGACAG; 1␣-hydrox ylase CCGCGGGCTATGCTGGA AC͞CTCTGGGCA A AGG-CAAACATCTGA; and 24-hydroxylase TGGGAAGATGAT-GGTGACCC͞ACTGTTCCTTTGGGTAGCGT. All amplicons were 200 -500 bp and were sequenced to confirm specificity of amplification. Throughout real-time PCR analysis, product identities were confirmed by melting curve analysis. The quantification of each gene was relative to a standard curve generated from a serially diluted sample. The relative amount of each experimental gene was then normalized to the abundance of the housekeeping gene ␤-actin. These values were standardized such that a maximum value of 1.0 was assigned to the group with the highest gene expression.
Statistical Analysis. The two-tailed Student's t test was used to quantify statistical differences between experimental groups. Results are expressed as mean Ϯ SE.
Results

Serum Analysis.
To study the effects of 1,25(OH) 2 D 3 and calcium on renal VDR expression, vitamin D-deficient and vitamin D-replete mice were placed pairwise on diets containing four levels of calcium with or without 50 ng of 1,25(OH) 2 D 3 per day. As indicated in Table 1 , the vitamin D-deficient mice on the 0.02% calcium diet had the lowest serum calcium. Dietary supplementation of 50 ng of 1,25(OH) 2 D 3 per day was insufficient to raise serum calcium in these mice, whereas 50 ng of 1,25(OH) 2 D 3 caused a significant increase in serum calcium in all mice that had dietary calcium of at least 0.25%. This finding suggests that a daily dietary intake of 50 ng of 1,25(OH) 2 D 3 is sufficient for vitamin D-induced intestinal calcium uptake, but is insufficient for 1,25(OH) 2 D 3 -induced mobilization of calcium from bone. Similar observations were made with the vitamin D-replete mice, although the vitamin D-replete mice on the 0.02% calcium diet had significantly higher serum calcium values than did the calcium-restricted, vitamin D-deficient mice. Because the only source of calcium appearing in the blood of these mice is bone (23) Nonobese diabetic mice were fed a purified diet that contained 0.02%, 0.25%, 0.47%, or 1.20% calcium with or without 50 ng of 1,25(OH) 2D3 per mouse per day. Study length was 3 weeks for vitamin D-deficient, calciumrestricted mice and 200 days for all other groups. Serum calcium was determined weekly by atomic absorption spectrometry (n ϭ 4). At death, serum was collected and pooled, and the 1, To further our understanding of the regulation of renal VDR by 1,25(OH) 2 D 3 and calcium, we performed real-time PCR experiments to quantify relative VDR mRNA between dietary groups. The VDR mRNA in vitamin D-deficient mice was expressed at a low basal level, regardless of dietary calcium (Fig. 2) . Vitamin D-deficient mice supplemented with 50 ng of 1,25(OH) 2 D 3 showed a dramatic 8-to 10-fold increase in renal VDR transcript levels when at least 0.25% calcium was present in the diet. 1,25(OH) 2 D 3 supplementation did not increase renal VDR mRNA in mice fed the calcium-restricted diet. Combined, these studies demonstrate that both 1,25(OH) 2 D 3 and calcium are required for expression of renal VDR mRNA above basal levels.
In vitamin D-replete mice, the VDR mRNA levels were lowest in the 0.02% calcium group, confirming the requirement of calcium for renal VDR mRNA expression. In the calciumrestricted mice, supplementation with 1,25(OH) 2 D 3 did not significantly increase the abundance of VDR transcript, likely because of the lack of calcium. Mice fed calcium-fortified diets expressed consistently high levels of relative VDR transcript because of their endogenous production of 1,25(OH) 2 D 3 and consumption of calcium. This study further suggested that 1,25(OH) 2 D 3 and calcium are required to activate VDR transcription and increase the relative VDR mRNA. To further characterize the metabolic status of the mice in this study, the transcript levels of the two primary vitamin D metabolism enzymes were quantified. The 1␣-hydroxylase is responsible for the conversion of 25-hydroxyvitamin D 3 to 1,25(OH) 2 D 3 . This enzyme is primarily expressed in the kidney, and is stimulated by parathyroid hormone (PTH), and suppressed by 1,25(OH) 2 D 3 (24, 25) . As was expected, the 1␣-hydroxylase transcript levels were highest in the vitamin Ddeficient mice, and in the mice fed the calcium-restricted diets (Fig. 3) . These mice had the lowest serum calcium values, and likely expressed high amounts of PTH, because PTH expression is inversely related to serum calcium (26) . In the vitamin D-deficient study, 50 ng of 1,25(OH) 2 D 3 nearly completely abolished 1␣-hydroxylase expression in mice consuming dietary calcium. It is difficult to separate the direct effects of 1,25(OH) 2 D 3 on repression of the 1␣-hydroxylase gene from the secondary effects of increased serum calcium and decreased PTH. In the vitamin D-replete study, 50 ng of 1,25(OH) 2 D 3 had minimal impact on relative 1␣-hydroxylase mRNA in mice consuming dietary calcium, because the 1␣-hydroxylase expression was consistently low due to endogenous production of 1,25(OH) 2 D 3 .
The 24-hydroxylase is the major catabolic enzyme responsible for the degradation of 1,25(OH) 2 D 3 . The 24-hydroxylase promoter contains two vitamin D-response elements and has been well characterized as a target gene for activation by 1,25(OH) 2 D 3 (27, 28) . 24-Hydroxylase mRNA was undetectable in vitamin D-deficient mice, further confirming the vitamin D-deficient status of these mice (Fig. 4) . Vitamin D-deficient mice receiving 50 ng of 1,25(OH) 2 D 3 produced significant amounts of 24-hydroxylase mRNA only if they were consuming dietary calcium. This finding was almost certainly due to the fact that upregulation of the 24-hydroxylase by 1,25(OH) 2 D 3 is receptor dependent, and, as was shown in Fig. 1 , the VDR expression in the vitamin D-deficient, calcium-restricted mice was very low. In the calcium-restricted, vitamin D-replete mice, 24-hydroxylase transcript was low yet detectable because of the very high levels of 1,25(OH) 2 D 3 (Table 1 ) and low but sufficient expression of VDR. When at least 0.25% calcium was present in the diet, supplementation with 1,25(OH) 2 D 3 resulted in a significant increase in the 24-hydroxylase mRNA. This increase was not significant for the vitamin D-replete 1.20% calcium group, because these mice had elevated serum calcium values and, thus, had relatively high 24-hydroxylase mRNA levels without supplementation of 1,25(OH) 2 D 3 . The reciprocal regulation of the renal 1␣-hydroxylase and 24-hydroxylase observed in this study further demonstrates the influence of 1,25(OH) 2 D 3 and calcium on the regulation of vitamin D hormone levels.
Discussion
We have conducted a comprehensive, long-term study examining the effects of 1,25(OH) 2 D 3 and dietary calcium on mouse renal VDR expression. In this study we have shown that 50 ng of 1,25(OH) 2 D 3 can cause a 10-fold increase in the expression of renal VDR in a vitamin D-deficient mouse. Previous studies (12, 14, 17) in vitamin D-deficient rats have shown a 2-to 4-fold increase in renal VDR content in response to 1,25(OH) 2 D 3 . The more dramatic increase observed in this study may be due to species differences, variances in dosage and administration (dietary versus injection or osmotic pump), or the significantly greater length of this 200-day study. In vitamin D-deficient rats, Uhland-Smith and DeLuca (17) did observe a greater increase in VDR expression after 8 weeks of 1,25(OH) 2 D 3 treatment (4-fold increase versus controls) than after 4 weeks (2-fold increase versus controls) of 1,25(OH) 2 (10, 13, 18) . The studies that examined changes in renal VDR mRNA in response to 1,25(OH) 2 D 3 administration ranged from a single i.p. injection (10) to daily injections for one week (13) . Because the half-life of 1,25(OH) 2 D 3 is Ͻ6 h in the mouse (29) , it is possible that daily injections of 1,25(OH) 2 D 3 did not alter the transcript level, or caused a temporal increase that was not detected by the Northern analysis. In the longer term studies that explored the regulation of rat renal VDR by 1,25(OH) 2 D 3 and calcium, VDR mRNA values were not reported (14, 17) .
The kidney is a vitamin D target tissue critical in the reabsorption of urinary calcium. The increase in renal VDR caused by 1,25(OH) 2 D 3 is most likely a result of increased transcription and ligand-induced stabilization, and could serve as a means of signal amplification. The kidney is also an important tissue for the regulation of the metabolism of 1,25(OH) 2 D 3 , because both the 1␣-hydroxylase and 24-hydroxylase are expressed in the renal proximal tubular cells. Down-regulation of renal VDR in response to hypocalcemia may be a protective measure to block 1,25(OH) 2 D 3 -mediated suppression of the 1␣-hydroxylase and induction of the 24-hydroxylase, resulting in a net increase in serum 1,25(OH) 2 D 3 levels (15).
The molecular mechanism by which 1,25(OH) 2 D 3 and calcium regulate renal VDR expression remains unclear. These experiments demonstrate that 1,25(OH) 2 D 3 and calcium are both required to increase renal VDR mRNA levels. Sequence analysis of the mouse and human VDR promoters does not reveal any vitamin D response elements, and no response to 1,25(OH) 2 D 3 has been detected during reporter-gene analysis, suggesting that 1,25(OH) 2 D 3 does not directly activate expression of its receptor (30) (31) (32) . Further experiments must be performed to discern the extent of transcriptional and posttranscriptional regulation, identify regulatory pathways and signaling molecules, and elucidate the mechanism behind the tissue specificity of this regulation.
